Correlation Between Serum Adiponectin And Resistin Levels And Degree of Hepatic Fibrosis in MASlD With type2 Diabetes Mellitus

Sohag University

Status: Not yet enrolling

Conditions: Hepatic Fibrosis

Treatments: Diagnostic Test: fibroscan; Diagnostic Test: serum Adiponectine and Resistin

Study type: Observational

Funder types: Other

Identifiers

NCT06715189

Soh-Med-24-11--5MD

Details and patient eligibility

About

Metabolic dysfunction asociated steatotic liver disease prevalence is 25%world wide diabetic patients have a risk for MASLD then have hepatic fibrosis so we study correlation Between Serum Adiponectin And Resistin Levels And Degree of Hepatic fibrosis In Metabolic dysfunction asociated steatotic liver disease in patients with type2 Diabetes Mellitus

Enrollment: 80 estimated patients

Sex: All

Ages: 30 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• patients of both sex who have type2 Diabetes Mellitus for less than five years

Exclusion Criteria:alcholics ,chronic liver disease elevated liver functions , sever infection

Trial design

80 participants in 2 patient groups

MASLD patients with hepatic fibrosis

Description:

MASLD with hepatic fibrosis with type 2 diabetes mellitus

Treatment:

Diagnostic Test: serum Adiponectine and Resistin

Diagnostic Test: fibroscan

MASLD without hepatic fibrosis

Description:

MASLD with out hepatic fibrosis with type 2 diabetes mellutis

Treatment:

Diagnostic Test: serum Adiponectine and Resistin

Diagnostic Test: fibroscan